Are antihypertensive drugs associated with abdominal aortic aneurysms?

Journal of Vascular Surgery

Volumn 36, Issue 4, 2002, Pages 751-757

  Wilmink, Antonius B M ^a   Vardulaki, Katerina A ^b   Hubbard, Catherine S Ff ^c   Day, Nicholas E ^d   Ashton, Hilary A ^e   Scott, Alan P ^e   Quick, Clive R G ^c  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b Audit Commission   (United Kingdom)

^c HINCHINGBROOKE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e ST RICHARD S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ABDOMINAL AORTA ANEURYSM; AGED; ANAMNESIS; AORTA; AORTA WALL; ARTICLE; CONTROLLED STUDY; ELASTICITY; FEMALE; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MUSCLE STIFFNESS; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOIMMUNOASSAY; SCREENING; SMOKING; UNITED KINGDOM; ABDOMINAL AORTA; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ECHOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK; RISK ASSESSMENT; VASCULAR PATENCY;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; CALCIUM CHANNEL BLOCKERS; COLLAGEN; DIURETICS; FEMALE; HUMANS; MALE; ODDS RATIO; RISK ASSESSMENT; VASCULAR PATENCY;

EID: 0036779819     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.126550     Document Type: Article

References (45)

1. Adiseshiah M, MacSweeney S, Henney A, Poulter N, Powell J, Greenhalgh R. Grand Round: abdominal aortic aneurysm; report of a meeting of physicians and scientists. Lancet 1993;341:215-20.
2. Dobrin P. Mechanics of normal and diseased blood vessels. Ann Vasc Surg 1988;2:283-94.
3. MacSweeney ST, Powell JT, Greenhalgh RM. Pathogenesis of abdominal aortic aneurysm. Br J Surg 1994;81:935-41.
4. Rijbroek A, Moll FL, van Dijk HA, Meijer R, Jansen JW. Inflammation of the abdominal aortic aneurysm wall. Eur J Vasc Surg 1994;8:41-6.
5. Ghorpade A, Baxter BT. Biochemistry and molecular regulation of matrix macromolecules in abdominal aortic aneurysms. Ann N Y Acad Sci 1996;800:138-50.
6. Halloran BG, Baxter BT. Pathogenesis of aneurysms. Semin Vasc Surg 1995;8:85-92.
7. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995;15: 1145-51.
8. Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 1998;102:1900-10.
9. Koch AE, Haines GK, Rizzo R, Radosevich JA, Pope RM, Robinson PG, et al. Human abdominal aortic aneurysms: analysis suggesting an immune-mediated response. Am J Path 1990;137:1199-1213.
10. Koch AE, Kunkel SL, Pearce WH, Shah MR, Parikli D, Evanoff HL, et al. Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol 1993;142:1423-31.
11. Brophy CM, Marks WH, Reilly JM, Tilson MD. Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: a preliminary report. J Surg Res 1991;50:653-7.
12. Pearce W, Koch A. Cellular components and features of immune response in abdominal aortic aneurysms. Ann N Y Acad Sci 1996;800: 175-85.
13. Sakalihasan N, Delvenne P, Nusgens BV, Limet R, Lapiere CM. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 1996;24:127-33.
14. Tamarina NA, McMillan WD, Shively VP, Pearce WH. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 1997;122:264-71.
15. McMillan WD, Pearce WH. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 1999;29:122-7.
16. Holmes DR, Petrinec D, Wester W, Thompson RW, Reilly JM. Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. J Surg Res 1996;63:305-9.
17. Boyle JR, McDermott E, Crowther M, Wills AD, Bell PRF, Thompson MM. Doxycycline inhibits degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg 1998;27:354-61.
18. Curci JA, Petrinec D, Liao S, Golub LM, Thompson RW. Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg 1998;28:1082-93.
19. Boyle J, Loftus I, Goodall S, Crowther M, Bell P, Thompson M. Amlodipine potentiates metalloproteinase activity and accelerates elastin degradation in a model of aneurysmal disease. Eur J Vasc Endovasc Surg 1998;16:408-14.
20. Wojtowicz-Praga S, Dickson R, Hawkins M. Matrix-metalloproteinase inhibitors. Invest New Drugs 199;15:61-75.
21. Li Y, Feldman A. Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications. Drugs 2001;61:1239-52.
22. Klevay LM. Trace elements, atherosclerosis, and abdominal aneurysms. Ann N Y Acad Sci 1996;800:239-42.
23. Wilmink A, Quick C. Epidemiology and potential for prevention of abdominal aortic aneurysm. Br J Surg 1998;85:155-62.
24. Scott RA, Wilson NM, Ashton HA, Kay DN. Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. Br J Surg 1995;82:1066-70.
25. Morris GE, Hubbard CS, Quick CR. An abdominal aortic aneurysm screening program for all males over the age of 50 years. Eur J Vasc Surg 1994;8:156-60.
26. Wilmink A, Hubbard C, Quick C. Quality of the measurement of the infrarenal aortic diameter by ultrasound. J Med Screening 1997;4:49-53.
27. Vardulaki K, Prevost T, Walker N, Day N, Wilmink A, Quick C, et al. Growth rates and risk of rupture of abdominal aortic aneurysms. Br J Surg 1998;85:1674-80.
28. MacSweeney ST, Young G, Greenhalgh RM, Powell JT. Mechanical properties of the aneurysmal aorta. Br J Surg 1992;79:1281-4.
29. Sonesson B, Hansen F, Laune T. The mechanical properties of elastic arteries in Ehlers-Danlos syndrome. Eur J Vasc Surg 1997;14:258-64.
30. Länne T, Sonesson B, Bergqvist D, Bengtsson H, Gufstafsson D. Diameter and compliance in the male human abdominal aorta: influence of age and aortic aneurysm. Eur J Vasc Surg 1992;6:178-84.
31. Prockop D, Kirivikko K, Tuderman L, Guzman N. The biosynthesis of collagen and its disorders I. N Engl J Med 1979;301:13-23.
32. Ristell J, Niemi S, Trivedi P, Mäentusa O, Mowat A, Ristelli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988;34:715-18.
33. Satta J, Juvonen T, Haukipuro K, Juvonen M, Kairaluoma MI. Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. J Vasc Surg 1995;22:155-60.
34. Clayton D, Hills M. Statistical models in epidemiology. Oxford: Oxford University Press; 1993.
35. Campa JS, Greenhalgh RM, Powell JT. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 1987;65:13-21.
36. He CM, Roach MR. The composition and mechanical properties of abdominal aortic aneurysms. J Vasc Surg 1994;20:6-13.
37. Gandhi RH, Irizarry E, Cantor JO, Keller S, Nackman GB, Halpern VJ, et al. Analysis of elastin cross-linking and the connective tissue matrix of abdominal aortic aneurysms. Surgery 1994;115:617-20.
38. Sakalihasan N, Heyeres A, Nusgens BV, Limet R, Lapiere CM. Modifications of the extracellular matrix of aneurysmal abdominal aortas as a function of their size. Eur J Vasc Surg 1993;7:633-7.
39. Gargiulo M, Stella A, Spina M, Faggioli G, Cenacchi G, Degani A, et al. Content and turnover of extracellular matrix protein in human "non-specific" and inflammatory abdominal aortic aneurysms. Eur J Vasc Surg 1993;7:546-53.
40. White JV, Haas K, Phillips S, Comerota AJ. Adventitial elastolysis is a primary event in aneurysm formation. J Vasc Surg 1993;17:371-80.
41. White JV, Mazzacco SL. Formation and growth of aortic aneurysms induced by adventitial elastolysis. Ann N Y Acad Sci 1996;800:97-120.
42. Lindholt J. Considerations and experiences of screening for abdominal aortic aneurysm. Aarhus: University of Aarhus; 1998. p. 132.
43. Dobrin PB, Mrkvicka R. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg 1994;2:484-8.
44. Poldermans D, Boersma E, Bax J, Thomson I, Paelinck B, van de Ven L, et al. Bisoprolol reduces cardiac death and myocardial infarction as long as two years after successful vascular surgery. Eur Heart J 2001;22: 1353-8.
45. Poldermans D, Boersma E, Bax J, Thomson I, van de Ven L, Blankensteijn J, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999;341:1789-91.